Unknown

Dataset Information

Neoantigen vaccine platforms in clinical development: understanding the future of personalized immunotherapy.


ABSTRACT:

Introduction

Derived from genetic alterations, cancer neoantigens are proteins with novel amino acid sequences that can be recognized by the immune system. Recent evidence demonstrates that cancer neoantigens represent important targets of cancer immunotherapy. The goal of cancer neoantigen vaccines is to induce neoantigen-specific immune responses and antitumor immunity, while minimizing the potential for autoimmune toxicity. Advances in sequencing technologies, neoantigen prediction ?algorithms,? and other technologies have dramatically improved the ability to identify and prioritize cancer neoantigens. These advances have generated considerable enthusiasm for ?the ?development of neoantigen vaccines. Several neoantigen vaccine platforms are currently being evaluated in early pha

SUBMITTER: Supabphol S 

PROVIDER: S-EPMC8327784 | biostudies-literature | 2021 May

REPOSITORIES: biostudies-literature